Akebia Therapeutics
AKBA
#6350
Rank
A$0.97 B
Marketcap
$3.72
Share price
4.39%
Change (1 day)
76.47%
Change (1 year)

EPS for Akebia Therapeutics (AKBA)

EPS in 2023 (TTM): -$0.97

According to Akebia Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.00. In 2022 the company made an earnings per share (EPS) of -$0.80 an increase over its 2021 EPS that were of -$2.66.

EPS history for Akebia Therapeutics from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.9721.52%
2022-$0.80-70%
2021-$2.66-38.63%
2020-$4.3317.37%
2019-$3.692.79%
2018-$3.5931.2%
2017-$2.74-51.39%
2016-$5.6357.89%
2015-$3.56-94.83%
2014-$68.97589.75%
2013-$10.00

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$22.12-2,310.94%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.85-684.38%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$22.02-2,300.83%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.55 154.69%๐Ÿ‡บ๐Ÿ‡ธ USA